PREVNAR
PREVNAR
Discontinued
DIN Number
02244081
Drug Class
Human
Market Date
Jun 20, 2001
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02244081
AIG Number0844301002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AL02 PNEUMOCOCCUS, PURIFIED POLYSACC.ANTIGEN CONJUGATED
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (8)
CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEINActive
Strength: 20 MCG / 0.5 ML
Monograph: CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14Active
Strength: 2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CActive
Strength: 2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19FActive
Strength: 2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23FActive
Strength: 2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4Active
Strength: 2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6BActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9VActive
Strength: 2 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V